Filing Details

Accession Number:
0001209191-22-061532
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 19:01:28
Reporting Period:
2022-12-13
Accepted Time:
2022-12-15 19:01:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI Pharmaceutical Preparations (2834) 364742850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585699 Sharon Mates C/O Intra-Cellular Therapies, Inc.
430 East 29Th Street
New York NY 10016
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-13 33,083 $55.00 1,100,309 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.